Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseasesQian Huang, Yi Huang, Yi Ru et al.|Science Advances|2024Cited by 153
Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating ironYi Ru, Yi Huang, Ying‐Li Luo et al.|International Immunopharmacology|2024Cited by 28
Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injuryXianyu Luo, Yi‐Hsiang Huang, Maoyuan Linghu et al.|Free Radical Biology and Medicine|2025Cited by 17
Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injuryMaoyuan Linghu, Yi Huang, Xianyu Luo et al.|Cell chemical biology|2025Cited by 14
GNF-5837 attenuates acute liver injury by inhibiting oxidative stressXinru Zhou, Yi‐Hsiang Huang, Qian Huang et al.|Molecular Biology Reports|2025Cited by 3